Valuation: West Pharmaceutical Services, Inc.

Market Cap 24.92B 21.55B 20.13B 18.46B 34.73B 2,371B 35.28B 236B 92.69B 1,189B 93.57B 91.52B 3,930B P/E 2026 *
41.3x
P/E 2027 * 35.9x
Enterprise Value 24.41B 21.12B 19.72B 18.09B 34.03B 2,324B 34.57B 231B 90.82B 1,165B 91.68B 89.68B 3,850B EV / Sales 2026 *
7.23x
EV / Sales 2027 * 6.66x
Free-Float
92.89%
Yield 2026 *
0.25%
Yield 2027 * 0.27%
1 week+3.51%
Current month+3.51%
1 month-1.59%
3 months+11.65%
6 months+46.07%
Current year+32.27%
1 week 296.2
Extreme 296.2
306.7
1 month 286.5
Extreme 286.5
346.25
3 years 168.65
Extreme 168.65
386.1
5 years 168.65
Extreme 168.65
418.6
Manager TitleAgeSince
Chief Executive Officer 56 23/04/2015
Director of Finance/CFO 57 03/08/2025
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Director/Board Member 65 31/01/2011
Director/Board Member 69 06/03/2011
Director/Board Member 56 11/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%+3.51%+48.83%-10.77% 24.92B
-0.14%+2.00%-18.36%-0.59% 187B
+1.44%+2.07%-4.47%+2.88% 112B
-1.40%+2.93%+15.11%+71.75% 61.15B
+0.65%+3.91%+37.08%+53.44% 54.39B
-0.12%+6.79%-5.77%-35.74% 48.17B
+2.08%+1.56%+10.93%-29.94% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+47.20%-6.50% 24.92B
+2.45%+3.97%+0.52%+4.99% 23.14B
Average +0.96%+1.45%+14.56%+5.50% 63.64B
Weighted average by Cap. +0.53%+2.02%+2.63%+7.96%

Financials

2026 *2027 *
Net sales 3.37B 2.92B 2.73B 2.5B 4.7B 321B 4.78B 31.98B 12.55B 161B 12.67B 12.39B 532B 3.59B 3.1B 2.9B 2.66B 5B 341B 5.08B 34B 13.34B 171B 13.47B 13.18B 566B
Net income 615M 532M 496M 455M 857M 58.49B 870M 5.82B 2.29B 29.32B 2.31B 2.26B 96.92B 701M 607M 566M 520M 977M 66.74B 993M 6.65B 2.61B 33.45B 2.63B 2.58B 111B
Net Debt -503M -435M -407M -373M -701M -47.9B -713M -4.77B -1.87B -24.01B -1.89B -1.85B -79.37B -1.04B -899M -839M -770M -1.45B -98.89B -1.47B -9.85B -3.87B -49.57B -3.9B -3.82B -164B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
-
Date Price Change
07/08/26 €306.60 +1.69%
06/08/26 €301.50 -0.69%
05/08/26 €303.60 +0.45%
04/08/26 €302.25 +0.03%
03/08/26 €302.15 +2.01%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
354.07USD
Average target price
404.73USD
Spread / Average Target
+14.31%

Quarterly revenue - Rate of surprise